Radu Pislariu, MD

President and CEO
Laurent Pharmaceuticals Inc., Canada

Poster(s):

• (168) Results from APPLAUD Phase 2 Study with Pro-Resolution Drug Candidate LAU-7b in Adults with Cystic Fibrosis
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (657) Combinatory treatment of LAU-7b with triple therapy results in improved lung physiology and restored fatty acid and lipid levels
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET